A workshop hosted by the International Probiotics Association (IPA) in Washington, DC will tackle some of the key issues facing the probiotics sector, including positions from FDA and FTC on NDIs and claims substantiation.
According to UNPA president Loren Israelsen there has been plenty of recent innovation within the dietary supplement despite complaints to the contrary. But the NDI draft guidance could bring that to a screeching halt.
Under the combined pressure of industry and lawmakers, the federal Drug Enforcement Administration has backed off its emergency listing of kratom to the schedule 1 list of controlled substances.
The NDI draft guidance contains several points that are potentially issues for probiotics, and there appears to be a disconnect with the GRAS (generally recognized as safe) process, says a leading industry expert.
The NDI draft guidance offers a workable road map for companies willing to provide the safety information already called for by law, according to one ingredient supplier.
The Food and Drug Administration has extended the comment period on the updated draft version of the New Dietary Ingredients guidance. The new deadline for comments is Dec. 12.
In response to the recently re-released NDI draft guidance, the Natural Products Association (NPA) has said it is in the later stages of developing a comprehensive safe harbor list of pre-DSHEA dietary ingredients.
More than half (56%) of dietary supplement professionals said they haven’t read the Aug. 11 NDI guidance—and 6% said they haven’t read it, but told their boss that they did.
The drive toward shorter, cleaner labels and the oft-mentioned dearth of innovation in the supplement sphere are both factors of the maturation of the dietary supplement and functional foods industries, according to one expert.
From ingredient combinations to supercritical CO2 extraction to nanotechnology, here are some things to note from the new NDI draft guidance FDA released Aug. 11.
Over the last few years, the FDA has zeroed in on the dietary supplement industry. It has taken numerous actions against dietary supplements where it believes the ingredients pose health risks to the public. This scrutiny continues with the release...
In what has been called an ‘unprecedented’ move, the Food and Drug Administration has initiated a proceeding to take vinpocetine off the market despite a number of successful NDI notifications filed on the ingredient.
In addition to the areas that require clarification, the dietary supplement industry should look carefully and cautiously at the revised draft guidance for new dietary ingredient notifications, specifically at the economic impact of the FDA's new...
The devil is in the detail, and one detail easily missed in the new draft guidance for new dietary ingredient notifications is that self-affirmed GRAS is no longer mentioned as an ‘alternative’ to an NDI notification.
The new NDI draft guidance is very similar to the previous version, and yet the howls of outrage heard in 2011 are silent. What’s changed? Well, a lot…
The new draft guidance for new dietary ingredient notifications is “more positive than negative”, says Steve Mister, CEO of the Council for Responsible Nutrition.
The updated New Dietary Ingredients draft guidance, issued yesterday by the Food and Drug Administration, modifies the agency’s stance on the contentious issue of synthetic, nature-identical compounds. But not by much.
Master Files and a grandfathered list are among the highlights in the FDA’s new Draft Guidance for New Dietary Ingredient Notifications, released this morning.
A new policy by the American Medical Association on nootropics once again highlights the blurred edges of what can legitimately be called a ‘dietary supplement.’
With the recent elevation of dietary supplement oversight from a division to its own office at FDA’s Center for Food Safety and Applied Nutrition, the agency should renew its focus on reducing tainted supplements, improving compliance with good manufacturing...
Chinese supplier BGG is taking a big step to expand the global footprint of its ingredients with recent establishment of an office in Mexico City to go along with a new European site.
BGG subsidiary AlgaeLife Sciences, Inc. has successfully petitioned the US FDA with a New Dietary Ingredients notification (NDI) for its flagship product AstaZine Natural Astaxanthin.
The recent spate of FDA warning letters on the use of CBD as an ingredient in dietary supplements seems to have done little to dampen formulators’ enthusiasm for its use in new products. The situation is unprecedented in the herbal products sphere, observers...
The Natural Products Association enters its 80th year as the premier organization dedicated solely to the natural products industry in 2016. For those 80- years, our top priority has been and always will be enhancing, expanding and protecting our members’...
Despite an import ban on the substance, kratom-containing products continue to find their way into the country. In the latest action, the Food and Drug Administration has seized 90,000 bottles at a facility in Illinois.
By Steve Mister, president & CEO, the Council for Responsible Nutrition (CRN)
What a difference a year makes! Last January at this time, who in the industry would have predicted the New York Attorney General (AG) debacle in February? Or Senator Dick Durbin’s dietary supplement amendments on the defense authorization bill in May?...
What’s the future for botanical ingredient discovery? Experts differ on whether there are wholly new, useful species yet to be discovered, but agree that there are still more ingredients to be derived from source materials already in use.
The actions of New York Attorney General Eric Schneiderman have put an unprecedented pressure on the dietary supplement business, especially those companies dealing in herbal products.
As we enter the twilight days of 2015 the editors of NutraIngredients-USA become a reflective bunch. A lot of things happened this year, and here is our top 10 of most important events of the year…
A concentrate of an old dietary ingredient may need to file a new dietary ingredient notification, according to a new warning letter from the US Food and Drug Administration about bitter orange.
The USPLabs case demonstrates the tools investigators and prosecutors can bring to bear when looking into the dealings of a dietary supplement company, a former prosecutor says.
Dietary supplement trade associations have universally welcomed the Department of Justice’s nationwide sweep targeting more than 100 makers and marketers of dietary supplements for alleged fraudulent ingredients and illegal claims.
Following a recent meeting with high ranking FDA officials, Jarrow Rogovin, President/Founder, Jarrow Formulas, Inc, says that the dietary supplements industry has an historic opportunity to negotiate with the agency.
Former FDA official Dr Joshua Sharfstein, MD, has proposed a new paradigm for the regulation of dietary supplements. The underlying shift would be a move from an attitude of “benefit versus risk” to one of “access with safety.”
The declaration from FDA on picamilon that formed part of the lawsuit filed by the Oregon Attorney General sets a troubling precedent, said Steve Mister of the Council for Responsible Nutrition.
Cara Welch, PhD, acting deputy director of the Division of Dietary Supplement Programs at the Food and Drug Administration, signaled a change in emphasis at the agency with a willingness to publicly acknowledge the dietary supplement industry’s GMP successes...
The Food and Drug Administration is continuing enforcement actions based on the precepts laid out in the draft guidance on New Dietary Ingredients with a warning letter sent to a company marketing a product that contains the stimulant-like ingredient...
The NY AG affair has “tenderized” the dietary supplements industry in ways that other issues have not, and made it more vulnerable to other legal and regulatory attacks, said Steve Mister, president and CEO of the Council for Responsible Nutrition.
US Senators Dick Durbin and Richard Blumenthal sent a letter yesterday to the Food and Drug Administration asking the agency to take action against products containing the synthetic stimulant ingredient known as BMPEA, products which the pair called both “mislabeled...
The controversy surrounding the low-profile botanical Acacia rigidula and its purported amphetamine-like constituents seems to have caught regulators flat footed and has lead one trade association to ban the sale for its members of formulations featuring...
By By Douglas F. Gansler, Brian P. Kelly and Leslie L. Meredith
Editor’s note: The recent actions of New York Attorney General Eric Schneiderman have changed the enforcement landscape of the dietary supplements industry. This guest article from former Maryland Attorney General Douglas Gansler and his colleagues explore...
Prominent dietary supplement industry critic Dr Pieter Cohen has released a new study that shows that a synthetic stimulant was found in more than half of weight loss and sports performance products tested that listed Acacia rigidula as an ingredient...
The dietary supplement industry received a welcome breath of fresh air in a meeting of industry representatives with Rep. Ted Lieu, the newly elected Democrat in California’s 33rd Congressional District. The meeting was arranged by Jarrow Formulas and...
The high rate of failure in New Dietary Ingredient notifications has led some companies to seek workarounds. Anecdotal evidence gathered by NutraIngredients-USA shows that companies are increasingly leaning on GRAS status as a way to avoid having to enter...
The Food and Drug Administration has issued another warning letter taking a company to task for marketing a product with an ingredient that lacks a New Dietary Ingredient filing. But one observer wonders why more such letters haven’t come from the agency.